Position in KRYS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$805,408
+$180,378 QoQ
Shares Held
2,167
-52.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#207
of 419 holders
Holding Since
Dec 2024
4 quarters on record
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Summit Global Investments holds $20,708,446 across 14 Biotechnology names. KRYS ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
55,370 | $6,276,743 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,506 | $4,680,291 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,182 | $3,567,514 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
32,667 | $1,869,205 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
27,034 | $984,307 | |
| 6 | KRYS |
Krystal Biotech, Inc.
This page
|
2,167 | $805,408 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
7,542 | $615,200 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,937 | $612,266 |
All Filings in KRYS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $805,408 | 2,167 | Shares | Sole | 2026-08-03 | |
| 2025-06-30 | $625,030 | 4,547 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $849,393 | 4,711 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $540,946 | 3,453 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||